Microbial contamination of cord blood stem cells

被引:30
|
作者
Honohan, A
Olthuis, H
Bernards, AT
van Beckhoven, JM
Brand, A
机构
[1] Blood Bank Leiden Haaglanden, Sanquin Blood Supply Fdn, NL-2301 CD Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands
关键词
cord blood; low microbial load; low-pathogens; microbial contamination;
D O I
10.1046/j.1423-0410.2002.00133.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives After storage,low levels of contaminating bacteria in standard blood components can reach bacteraemic levels, causing severe transfusion-associated sepsis. For cord blood (CB), the significance of low levels of contaminating bacteria and the optimal detection method is unknown and not supported by available guidelines. Materials and Methods Spiking experiments and testing of various subfractions of CB units were used to determine the behaviour of bacteria during centrifugation, freezing and thawing. For routine testing of CB, different volumes were compared for the detection of potential pathogens and micro-organisms of low pathogenicity. Results Centrifugation, as applied to CB fractionation, does not show concentration of bacteria in any particular fraction and supports the possibility of culture of waste fractions. Dimethylsulphoxide (DMSO) and freezing does not affect the viability of bacteria under the conditions used in this study. Owing to the low contamination level, a large sample volume of 20 ml was more sensitive than a 10-ml sample volume. Eighty five per cent of the isolated strains can be considered to be of low pathogenicity. Conclusion When an optimal waste fraction sample volume of 20 ml was cultured, the contamination rate of CB was found to be approximate to 13%, with low levels of > 1 colony-forming unit (CFU)/ml. Such levels of bacteria of low pathogenicity are expected to be of clinical importance only when CB is expanded in vitro for a prolonged period of time.
引用
收藏
页码:32 / 38
页数:7
相关论文
共 50 条
  • [1] Physical and microbial contamination monitoring in the processing of peripheral blood stem cells
    Langer, U
    Krämer, I
    Jahn, B
    Jansen, B
    Schwuléra, U
    Huber, C
    PHARMAZEUTISCHE INDUSTRIE, 1999, 61 (08): : 748 - 758
  • [2] Cord blood stem cells
    Rajab, Khalil E.
    Sequeira, Reginald P.
    SAUDI MEDICAL JOURNAL, 2009, 30 (02) : 175 - 183
  • [3] Development of a PCR assay to detect mycoplasma contamination in cord blood hematopoietic stem cells
    Tabatabaei-Qomi, Reza
    Sheykh-Hasan, Mohsen
    Fazaely, Hoda
    Kalhor, Naser
    Ghiasi, Mahdieh
    IRANIAN JOURNAL OF MICROBIOLOGY, 2014, 6 (04) : 281 - 284
  • [4] Microbial contamination of peripheral blood stem cell collections
    Attarian, H
    Bensinger, WI
    Buckner, CD
    McDonald, DL
    Rowley, SD
    BONE MARROW TRANSPLANTATION, 1996, 17 (05) : 699 - 702
  • [5] Banking on cord blood stem cells
    Webb, Sarah
    NATURE BIOTECHNOLOGY, 2013, 31 (07) : 585 - 588
  • [6] Banking on cord blood stem cells
    Sullivan, Michael J.
    NATURE REVIEWS CANCER, 2008, 8 (07) : 554 - 563
  • [7] Interest of cord blood stem cells
    de Wynter, EA
    Testa, NG
    BIOMEDICINE & PHARMACOTHERAPY, 2001, 55 (04) : 195 - 200
  • [8] Banking on cord blood stem cells
    Sarah Webb
    Nature Biotechnology, 2013, 31 : 585 - 588
  • [9] Umbilical cord blood stem cells
    Kelly, P
    Kurtzberg, J
    Vichinsky, E
    Lubin, B
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1997, 4 (01): : 17 - 24
  • [10] Umbilical cord blood stem cells
    Rogers, I
    Casper, RF
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2004, 18 (06) : 893 - 908